Carboxyphosphamide
CAS: 22788-18-7
Rif. 3D-FC19801
1mg | Fuori produzione | ||
2mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione |
Informazioni sul prodotto
- 3-[[Amino[bis(2-chloroethyl)amino]phosphinyl]oxy]propanoic acidN,N-Bis(2-chloroethyl)phosphorodiamidate hydracrylic acidAsta 5754
- 3-[[Amino[bis(2-chloroethyl)amino]phosphinyl]oxy]propanoic acid
- Asta 5754
- Carboxycyclophosphamide
- Hydracrylic acid, N,N-bis(2-chloroethyl)phosphorodiamidate
- N,N-Bis(2-chloroethyl)-O-2-carboxyethylphosphorodiamide
- NSC 145124
- O-(2-Carboxyethyl) N,N-bis(2-chloroethyl)phosphorodiamidate
- Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-, ester with hydracrylic acid
- Propanoic Acid, 3-[[Amino[Bis(2-Chloroethyl)Amino]Phosphinyl]Oxy]-
- Vedi altri sinonimi
Carboxyphosphamide is a cytotoxic drug that belongs to the class of nitrogen mustards. It is used as an antineoplastic agent in the treatment of cancer. Carboxyphosphamide has been shown to inhibit DNA synthesis and protein synthesis, which are vital for cell division. The stability of this drug is due to its chemical structure, which prevents it from undergoing hydrolysis by esterases or glucuronidases. Carboxyphosphamide has been shown to be effective against autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. This drug also inhibits the production of enzymes such as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX).